According to the official website of the U.S. FDA, on June 5, the FDA released the final application materials for the renewal of the Modified Risk Tobacco Product (MRTP) order for Swedish Match U.S.A., Inc.'s General Snus product and announced the deadline for public comments. Public comments must be submitted to the docket by 11:59 PM Eastern Daylight Time on July 5, 2024, to ensure that the FDA can consider these opinions.
The application materials have been edited in accordance with applicable laws and can be found on the FDA website. Before making a final decision on the MRTP application, the FDA will consider all available information, including public comments and recommendations from the Tobacco Products Scientific Advisory Committee (TPSAC).
The FDA recently announced that the TPSAC meeting will be held on June 26, 2024 to discuss these renewal applications. The public can participate in person or online. Written submissions can be sent to the contact person by June 20, 2024. Individuals wishing to make a formal oral presentation should notify the contact person by 5 p.m. (Eastern Daylight Time) on June 11, 2024.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
